The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial
Contacte-nos
Sede da ERA
- Rua dos Mercados 16/A
- I-43126 Parma – Itália
- Telefone: +39 0521 989078
- Fax: +39 0521 959242
Sede Registrada da ERA
- c/o PKF Littlejohn, 15 Westferry Circus,
- Canary Wharf
- London E14 4HD – Reino Unido